Clinical Trials Directory

Trials / Completed

CompletedNCT06997601

Serratus Posterior Superior Intercostal Plane Block Versus Suprascapular Nerve Block and Axillary Nerve Block for Analgesia in Shoulder Arthroscopic Surgery

Serratus Posterior Superior Intercostal Plane Block Versus Suprascapular Nerve Block and Axillary Nerve Block for Analgesia in Shoulder Arthroscopic Surgery: A Randomized Clinical Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
50 (actual)
Sponsor
Tanta University · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

This study aims to compare the serratus posterior superior intercostal plane block and suprascapular nerve block and axillary nerve block for analgesia in shoulder arthroscopic surgery.

Detailed description

Controlling postoperative pain while minimizing opioid administration is particularly important because poor pain control is thought to be responsible for more than 60% of unplanned or prolonged hospitalizations. Suprascapular nerve block (SSNB) has been proposed based on the anatomic fact that the suprascapular nerve innervates approximately 70% of the shoulder joint, capsule, subacromial space, acromioclavicular joint, and coracoacromial ligament, with the remaining 30% thought to be innervated by the lateral pectoral and axillary nerve. The combined SSNB and axillary nerve block (ANB) was proposed as a safe alternative to interscalene brachial plexus block (ISB) for providing anesthesia and postoperative analgesia for shoulder surgery. Serratus posterior superior intercostal plane block (SPSIPB) was described as a novel technique in a case series study of cadavers and five patients.

Conditions

Interventions

TypeNameDescription
OTHERSerratus posterior superior intercostal plane blockPatients will receive a serratus posterior superior intercostal plane block.
OTHERSuprascapular nerve block + Axillary nerve blockPatients will receive suprascapular nerve block + axillary nerve block.

Timeline

Start date
2025-05-31
Primary completion
2025-11-01
Completion
2025-11-01
First posted
2025-05-30
Last updated
2025-11-25

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06997601. Inclusion in this directory is not an endorsement.